Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Vivera Pharmaceuticals, Inc.
WARNING LETTER
•Vivera Pharmaceuticals, Inc.•April 1, 2021

Vivera Pharmaceuticals, Inc. – FDA Warning Letter, Apr 1, 2021

Record Details

The FDA issued a Warning Letter to hometestbox.com on July 26, 2021, following website reviews on March 3 and April 1, 2021. The letter addresses the sale of the VIVERA + OMECARE Home Specimen Collection Kit (COVxHT Kit), marketed for COVID-19 mitigation, prevention, treatment, diagnosis, or cure.

The FDA determined the COVxHT Kit is a device under section 201(h) of the Federal Food, Drug, and Cosmetic Act (the Act). It is deemed adulterated under section 501(f)(1)(B) of the Act, 21 U.S.C. § 351(f)(1)(B), because the firm lacks an approved premarket approval (PMA) or investigational device exemption (IDE). The kit is also misbranded under section 502(o) of the Act, 21 U.S.C. § 352(o), as the firm failed to notify the agency of its intent to introduce the device into commercial distribution, as required by section 510(k).

The introduction or delivery of this product into interstate commerce is prohibited under section 301(a) of the Act, and misbranding after shipment in interstate commerce is prohibited under section 301(k). Given the public health emergency

Company
Vivera Pharmaceuticals, Inc.
Inspection date
April 1, 2021
Product type
Devices
Office
Center for Devices and Radiological Health
People
  • Michael Nova
  • Timothy T. Stenzel (Director)
View Company Profile

ID · f2771172-d359-4b5e-95f0-ebb29db92a64

Violation Codes8
21 U.S.C. 321(h)21 U.S.C. 351(f)(1)(B)21 U.S.C. 360e(a)21 U.S.C. 360j(g)21 U.S.C. 352(o)21 U.S.C. 360(k)21 U.S.C. 331(k)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Other documents for Vivera Pharmaceuticals, Inc.
  • WARNING_LETTER - 2021-08-10August 10, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Vivera Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.